Magic mushroom compound is a potential treatment for patients with major depression Read More > June 8, 2016
Return of the lysergamides. Part II: Analytical and behavioural characterization of N6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2’S,4’S)-lysergic acid 2,4-dimethylazetidide (LSZ) Read More > June 6, 2016
Potential involvement of serotonergic signaling in ketamine’s antidepressant actions: A critical review Read More > June 2, 2016
Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review Read More > June 2, 2016
Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial Read More > June 1, 2016
Using the Theory of Planned Behavior to predict implementation of harm reduction strategies among MDMA/ecstasy users Read More > June 1, 2016
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality Read More > June 1, 2016
